Your browser doesn't support javascript.
loading
Deep learning analysis of clinical course of primary nephrotic syndrome: Japan Nephrotic Syndrome Cohort Study (JNSCS).
Kimura, Tomonori; Yamamoto, Ryohei; Yoshino, Mitsuaki; Sakate, Ryuichi; Imai, Enyu; Maruyama, Shoichi; Yokoyama, Hitoshi; Sugiyama, Hitoshi; Nitta, Kosaku; Tsukamoto, Tatsuo; Uchida, Shunya; Takeda, Asami; Sato, Toshinobu; Wada, Takashi; Hayashi, Hiroki; Akai, Yasuhiro; Fukunaga, Megumu; Tsuruya, Kazuhiko; Masutani, Kosuke; Konta, Tsuneo; Shoji, Tatsuya; Hiramatsu, Takeyuki; Goto, Shunsuke; Tamai, Hirofumi; Nishio, Saori; Nagai, Kojiro; Yamagata, Kunihiro; Yasuda, Hideo; Ichida, Shizunori; Naruse, Tomohiko; Nishino, Tomoya; Sobajima, Hiroshi; Akahori, Toshiyuki; Ito, Takafumi; Terada, Yoshio; Katafuchi, Ritsuko; Fujimoto, Shouichi; Okada, Hirokazu; Mimura, Tetsushi; Suzuki, Satoshi; Saka, Yosuke; Sofue, Tadashi; Kitagawa, Kiyoki; Fujita, Yoshiro; Mizutani, Makoto; Kashihara, Naoki; Sato, Hiroshi; Narita, Ichiei; Isaka, Yoshitaka.
Afiliação
  • Kimura T; Reverse Translational Research Project, Center for Rare Disease Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Osaka, Japan. t-kimura@nibiohn.go.jp.
  • Yamamoto R; Laboratory of Rare Disease Resource Library, Center for Rare Disease Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Osaka, Japan. t-kimura@nibiohn.go.jp.
  • Yoshino M; Health and Counseling Center, Osaka University, Suita, Osaka, Japan.
  • Sakate R; Reverse Translational Research Project, Center for Rare Disease Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Osaka, Japan.
  • Imai E; Reverse Translational Research Project, Center for Rare Disease Research, National Institutes of Biomedical Innovation, Health and Nutrition (NIBIOHN), Ibaraki, Osaka, Japan.
  • Maruyama S; Nakayamadera Imai Clinic, Takarazuka, Hyogo, Japan.
  • Yokoyama H; Department of Nephrology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
  • Sugiyama H; Department of Nephrology, Kanazawa Medical University School of Medicine, Kanazawa, Japan.
  • Nitta K; Department of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.
  • Tsukamoto T; Department of Nephrology, Tokyo Women's Medical University, Tokyo, Japan.
  • Uchida S; Department of Nephrology and Dialysis, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Osaka, Japan.
  • Takeda A; Department of Internal Medicine, Teikyo University School of Medicine, Tokyo, Japan.
  • Sato T; Kidney Disease Center, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Aichi, Japan.
  • Wada T; Department of Nephrology, JCHO Sendai Hospital, Sendai, Miyagi, Japan.
  • Hayashi H; Department of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.
  • Akai Y; Department of Nephrology, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.
  • Fukunaga M; First Department of Internal Medicine, Nara Medical University, Nara, Japan.
  • Tsuruya K; Division of Nephrology, Department of Internal Medicine, Toyonaka Municipal Hospital, Toyonaka, Osaka, Japan.
  • Masutani K; Department of Nephrology, Nara Medical University, Kashihara, Nara, Japan.
  • Konta T; Division of Nephrology and Rheumatology, Department of Internal Medicine, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
  • Shoji T; Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan.
  • Hiramatsu T; Department of Kidney Disease and Hypertension, Osaka General Medical Center, Osaka, Japan.
  • Goto S; Department of Nephrology, Konan Kosei Hospital, Konan, Aichi, Japan.
  • Tamai H; Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
  • Nishio S; Department of Nephrology, Anjo Kosei hospital, Anjo, Aichi, Japan.
  • Nagai K; Division of Rheumatology, Endocrinology and Nephrology, Hokkaido University Graduate School of Medicine, Sapporo, Japan.
  • Yamagata K; Department of Nephrology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
  • Yasuda H; Department of Nephrology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaragi, Japan.
  • Ichida S; Internal Medicine 1, Hamamatsu University School of Medicine, Hamamatsu, Shizuoka, Japan.
  • Naruse T; Department of Nephrology, Japanese Red Cross Nagoya Daiichi Hospital, Nagoya, Aichi, Japan.
  • Nishino T; Department of Nephrology, Kasugai Municipal Hospital, Kasugai, Aichi, Japan.
  • Sobajima H; Department of Nephrology, Nagasaki University Hospital, Nagasaki, Japan.
  • Akahori T; Department of Diabetology and Nephrology, Ogaki Municipal Hospital, Ogaki, Ogagki, Japan.
  • Ito T; Department of Nephrology, Chutoen General Medical Center, Kakegawa, Shizuoka, Japan.
  • Terada Y; Division of Nephrology, Shimane University Hospital, Izumo, Shimane, Japan.
  • Katafuchi R; Department of Endocrinology, Metabolism and Nephrology, Kochi Medical School, Kochi University, Kochi, Japan.
  • Fujimoto S; Kideny Unit, National Hospital Organization, Fukuoka-Higashi Medical Center, Koga, Fukuoka, Japan.
  • Okada H; Department of Hemovascular Medicine and Artificial Organs, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
  • Mimura T; Department of Nephrology, Saitama Medical University, Iruma, Saitama, Japan.
  • Suzuki S; Department of Nephrology, Gifu Prefectural Tajimi Hospital, Tajimi, Gifu, Japan.
  • Saka Y; Department of Nephrology, Kainan Hospital, Yatomi, Aichi, Japan.
  • Sofue T; Department of Nephrology, Yokkaichi Municipal Hospital, Yokkaichi, Mie, Japan.
  • Kitagawa K; Department of Cardiorenal and Cerebrovascular Medicine, Kagawa University, Takamatsu, Kagawa, Japan.
  • Fujita Y; Division of Internal Medicine, National Hospital Organization Kanazawa Medical Center, Kahoku, Kanazawa, Japan.
  • Mizutani M; Department of Nephrology, Chubu Rosai Hospital, Nagoya, Aichi, Japan.
  • Kashihara N; Department of Nephrology, Handa City Hospital, Handa, Aichi, Japan.
  • Sato H; Department of Nephrology and Hypertension, Kawasaki Medical School, Kurashiki, Okayama, Japan.
  • Narita I; Department of Nephrology, Endocrinology, and Vascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Miyagi, Japan.
  • Isaka Y; Division of Clinical Nephrology and Rheumatology, Kidney Research Center, School of Medical and Dental Sciences, Niigata University Graduate, Niigata, Japan.
Clin Exp Nephrol ; 26(12): 1170-1179, 2022 Dec.
Article em En | MEDLINE | ID: mdl-35962244
BACKGROUND: Prognosis of nephrotic syndrome has been evaluated based on pathological diagnosis, whereas its clinical course is monitored using objective items and the treatment strategy is largely the same. We examined whether the entire natural history of nephrotic syndrome could be evaluated using objective common clinical items. METHODS: Machine learning clustering was performed on 205 cases from the Japan Nephrotic Syndrome Cohort Study, whose clinical parameters, serum creatinine, serum albumin, dipstick hematuria, and proteinuria were traceable after kidney biopsy at 5 measured points up to 2 years. The clinical patterns of time-series data were learned using long short-term memory (LSTM)-encoder-decoder architecture, an unsupervised machine learning classifier. Clinical clusters were defined as Gaussian mixture distributions in a two-dimensional scatter plot based on the highest log-likelihood. RESULTS: Time-series data of nephrotic syndrome were classified into four clusters. Patients in the fourth cluster showed the increase in serum creatinine in the later part of the follow-up period. Patients in both the third and fourth clusters were initially high in both hematuria and proteinuria, whereas a lack of decline in the urinary protein level preceded the worsening of kidney function in fourth cluster. The original diseases of fourth cluster included all the disease studied in this cohort. CONCLUSIONS: Four kinds of clinical courses were identified in nephrotic syndrome. This classified clinical course may help objectively grasp the actual condition or treatment resistance of individual patients with nephrotic syndrome.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aprendizado Profundo / Síndrome Nefrótica Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Clin Exp Nephrol Assunto da revista: NEFROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aprendizado Profundo / Síndrome Nefrótica Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: Clin Exp Nephrol Assunto da revista: NEFROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão